Study With SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With IOP '= 21 mm Hg.

Trial Profile

Study With SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With IOP '= 21 mm Hg.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 23 Jul 2014

At a glance

  • Drugs Bamosiran (Primary)
  • Indications Ocular hypertension; Open-angle glaucoma
  • Focus Adverse reactions
  • Sponsors Sylentis
  • Most Recent Events

    • 07 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top